Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

Diabetes. 2003 Oct;52(10):2570-7. doi: 10.2337/diabetes.52.10.2570.

Abstract

Hyperglycemia increases the production of reactive oxygen species (ROS) from the mitochondrial electron transport chain in bovine endothelial cells. Because several studies have postulated a role for prostaglandins (PGs) in the glomerular hyperfiltration seen in early diabetes, we evaluated the effect of mitochondrial ROS on expression of the inducible isoform of cyclooxygenase (COX-2) in cultured human mesangial cells (HMCs). We first confirmed that incubation of HMC with 30 mmol/l glucose significantly increased COX-2 mRNA but not COX-1 mRNA, compared with 5.6 mmol/l glucose. Similarly, incubation of HMCs with 30 mmol/l glucose significantly increased mitochondrial membrane potential, intracellular ROS production, COX-2 protein expression, and PGE2 synthesis, and these events were completely suppressed by thenoyltrifluoroacetone or carbonyl cyanide m-chlorophenylhydrazone, inhibitors of mitochondrial metabolism, or by overexpression of uncoupling protein-1 or manganese superoxide dismutase. Furthermore, increased expression of COX-2 mRNA and protein was confirmed in glomeruli of streptozotocin-induced diabetic mice. In addition, hyperglycemia induced activation of the COX-2 gene promoter, which was completely abrogated by mutation of two nuclear factor kappaB (NF-kappaB) binding sites in the promoter region. Our results suggest that hyperglycemia increases mitochondrial ROS production, resulting in NF-kappaB activation, COX-2 mRNA induction, COX-2 protein production, and PGE2 synthesis. This chain of events might contribute to the pathogenesis of diabetic nephropathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone / pharmacology
  • Carrier Proteins / pharmacology
  • Cells, Cultured
  • Chelating Agents / pharmacology
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetic Neuropathies / etiology
  • Dose-Response Relationship, Drug
  • Gene Expression / physiology*
  • Glomerular Mesangium / cytology
  • Glomerular Mesangium / enzymology
  • Glomerular Mesangium / physiology*
  • Glucose / administration & dosage
  • Humans
  • Ion Channels
  • Ionophores / pharmacology
  • Isoenzymes / genetics*
  • Isoenzymes / metabolism
  • Membrane Proteins / pharmacology
  • Mice
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondrial Proteins
  • Promoter Regions, Genetic / physiology
  • Prostaglandin-Endoperoxide Synthases / genetics*
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • RNA, Messenger / metabolism
  • Reactive Oxygen Species / metabolism*
  • Superoxide Dismutase / pharmacology
  • Thenoyltrifluoroacetone / pharmacology
  • Uncoupling Protein 1

Substances

  • Carrier Proteins
  • Chelating Agents
  • Ion Channels
  • Ionophores
  • Isoenzymes
  • Membrane Proteins
  • Mitochondrial Proteins
  • RNA, Messenger
  • Reactive Oxygen Species
  • UCP1 protein, human
  • Ucp1 protein, mouse
  • Uncoupling Protein 1
  • Thenoyltrifluoroacetone
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Ptgs1 protein, mouse
  • Superoxide Dismutase
  • Glucose